The use of simulated and indirect treatment comparison methods to evaluate therapies’ comparative effectiveness: an interview with Gabriel Tremblay

Written by The Evidence Base

In this feature, Gabriel Tremblay (Purple Squirrel Economics Ltd.; NY, USA) shares his expert insight on the use of simulated and indirect treatment comparison (STC and ITC respectively) methods in cost—effectiveness research. In 2019, we reported on a novel study in which researchers employed indirect and simulated treatment comparison (ITC and STC respectively) methods to assess the comparative effectiveness of combination glasdegib and low-dose cytarabine over azacitidine or decitabine for older patients with acute myeloid leukemia. Now, lead study author Gabriel Tremblay (Purple Squirrel Economics Ltd.; NY, USA) exclusively discusses this work in greater depth, sharing his expert insight on...

To view this content, please register now for access

It's completely free